Quark Venture and GF Securities Invest US$25 Million in Microbion to Advance a New Class of Drugs That Combat Antibiotic-Resistant ...
VANCOUVER, BRITISH COLUMBIA and BOZEMAN, MONTANA--(Marketwired - Jan 5, 2017) - Today, Quark Venture Inc., a Vancouver-based health sciences venture capital company and GF Securities, a leading investment bank in Hong Kong, announced a US$25 million …